These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 7868950)
1. Protective effect of BCG against leprosy and its subtypes: a case-control study in southern Vietnam. Thuc NV; Abel L; Lap VD; Oberti J; Lagrange PH Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):532-8. PubMed ID: 7868950 [TBL] [Abstract][Full Text] [Related]
2. Effect of BCG on the risk of leprosy in an endemic area: a case control study. Muliyil J; Nelson KE; Diamond EL Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):229-36. PubMed ID: 2071979 [TBL] [Abstract][Full Text] [Related]
3. Protective effect of intradermal BCG against leprosy; a case-control study in central Brazil. Rodrigues ML; Silva SA; Neto JC; de Andrade AL; Martelli CM; Zicker F Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):335-9. PubMed ID: 1474274 [TBL] [Abstract][Full Text] [Related]
4. Protective efficacy of BCG against leprosy in São Paulo. Lombardi C; Pedrazzani ES; Pedrazzani JC; Filho PF; Zicker F Bull Pan Am Health Organ; 1996 Mar; 30(1):24-30. PubMed ID: 8919722 [TBL] [Abstract][Full Text] [Related]
5. BCG vaccination protects against leprosy in Venezuela: a case-control study. Convit J; Smith PG; Zuniga M; Sampson C; Ulrich M; Plata JA; Silva J; Molina J; Salgado A Int J Lepr Other Mycobact Dis; 1993 Jun; 61(2):185-91. PubMed ID: 8371026 [TBL] [Abstract][Full Text] [Related]
6. Effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of leprosy: a population-based case-control study in Yavatmal District, India. Zodpey SP; Ambadekar NN; Thakur A Public Health; 2005 Mar; 119(3):209-16. PubMed ID: 15661132 [TBL] [Abstract][Full Text] [Related]
8. [The protective efficacy of BCG against leprosy in São Paulo, Brazil]. Lombardi C; Pedrazzani ES; Pedrazzani JC; Ferreira Filho P; Zicker F Bol Oficina Sanit Panam; 1995 Nov; 119(5):415-21. PubMed ID: 8540997 [TBL] [Abstract][Full Text] [Related]
9. Neonatal BCG protection against leprosy: a study in Manaus, Brazilian Amazon. Cunha SS; Rodrigues LC; Pedrosa V; Dourado IM; Barreto ML; Pereira SM Lepr Rev; 2004 Dec; 75(4):357-66. PubMed ID: 15682973 [TBL] [Abstract][Full Text] [Related]
10. Case-control study of BCG vaccination as a risk factor for leprosy and tuberculosis in western Kenya. Orege PA; Fine PE; Lucas SB; Obura M; Okelo C; Okuku P Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):542-9. PubMed ID: 8151184 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness of bacillus Calmette-Guerin (BCG) vaccination in the prevention of leprosy; a case-finding control study in Nagpur, India. Zodpey SP; Shrikhande SN; Salodkar AD; Maldhure BR; Kulkarni SW Int J Lepr Other Mycobact Dis; 1998 Sep; 66(3):309-15. PubMed ID: 9934357 [TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy. Narang T; Kaur I; Kumar B; Radotra BD; Dogra S Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653 [TBL] [Abstract][Full Text] [Related]
13. Prognostic evaluation of cell mediated immunity in leprosy and correlation with clinicopathological status of leprosy patients. Aziz M; Malik A; Abbas SM; Vasenwala S; Kalam A Indian J Pathol Microbiol; 1996 Jan; 39(1):5-12. PubMed ID: 8755125 [TBL] [Abstract][Full Text] [Related]
14. Associations between HLA-DRB1 alleles and leprosy in an Indonesian population. Soebono H; Giphart MJ; Schreuder GM; Klatser PR; de Vries RR Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):190-6. PubMed ID: 9251590 [TBL] [Abstract][Full Text] [Related]
15. ILEP organisations should strive for high BCG coverage in communities at risk of leprosy. Velema JP; Ogbeiwi OI Lepr Rev; 2007 Jun; 78(2):88-101. PubMed ID: 17824479 [TBL] [Abstract][Full Text] [Related]
17. Anti-leprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: lepromin skin test results. Gormus BJ; Baskin GB; Xu K; Ratterree MS; Mack PA; Bohm RP; Meyers WM; Walsh GP Lepr Rev; 2002 Sep; 73(3):254-61. PubMed ID: 12449891 [TBL] [Abstract][Full Text] [Related]
18. Regional lymphadenitis following antileprosy vaccine BCG with killed Mycobacterium leprae. De Britto RL; Ramanathan VD; Gupte MD Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):12-9. PubMed ID: 9207749 [TBL] [Abstract][Full Text] [Related]
19. Comparative leprosy vaccine trial in south India. Gupte MD; Vallishayee RS; Anantharaman DS; Nagaraju B; Sreevatsa ; Balasubramanyam S; de Britto RL; Elango N; Uthayakumaran N; Mahalingam VN; Lourdusamy G; Ramalingam A; Kannan S; Arokiasamy J Indian J Lepr; 1998; 70(4):369-88. PubMed ID: 10189587 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of leprosy: a population-based case-control study in Raipur, India. Rahete NP; Zodpey SP; Kamble KM Indian J Public Health; 2007; 51(2):86-90. PubMed ID: 18240467 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]